title: [Severe pancytopenia and stomatitis in a patient treated with low-dose methostraxate].
abstract: A 68-year-old female patient presented at the emergency room with episodes of epistaxis, dysphagia and malaise. The patient had acute prerenal renal failure, probably in association with previous infection of the airways and treatment with NSAID's. Laboratory values revealed greatly decreased leukocyte and platelet counts as well as anemia. The patient had a diagnosis of a seronegative arthritis since 9 months and, therefore, was treated with low dose methotrexate (MTX) 10 mg/week. After exclusion of other causes, myelosupression was considered to be associated with low-dose MTX. After stopping MTX and treatment with folic acid leucocyte and platelet counts returned to normal and stomatitis recovered as well within nine days. We discuss the pharmacology of low-dose MTX and in particular the risk factors and prophylaxis of its toxicity. Renal function needs special attention in patients treated with low-dose MTX.
authors.affiliation: Abteilung für Klinische Pharmakologie & Toxikologie und Regionales Pharmakovigilance Zentrum Basel, Universitätsspital Basel. bruggisserm@uhbs.ch
authors.forename: M
authors.initials: M
authors.lastname: Bruggisser
authors.forename: A E
authors.initials: AE
authors.lastname: Rätz Bravo
authors.forename: S
authors.initials: S
authors.lastname: Krähenbühl
mesh_terms: D000068879:Adalimumab; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000633:toxicity*; D001168:Arthritis / Q000188:drug therapy*; D001706:Biopsy; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005260:Female; D005892:Gingivitis, Necrotizing Ulcerative / Q000139:chemically induced*; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage / Q000633:toxicity*; D010198:Pancytopenia / Q000139:chemically induced* / Q000175:diagnosis; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D013280:Stomatitis / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000068879:Adalimumab; D011241:Prednisone; D008727:Methotrexate